# Study to Evaluate the Pharmacokinetics and Pharmacodynamics of JMI-001

> **NCT03183297** · PHASE1 · UNKNOWN · sponsor: **Sen-Jam Pharmaceutical** · enrollment: 48 (estimated)

## Conditions studied

- Veisalgia

## Interventions

- **DRUG:** JMI-001
- **DRUG:** Naproxen
- **DRUG:** Fexofenadine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03183297
- **Lead sponsor:** Sen-Jam Pharmaceutical
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08
- **Primary completion:** 2017-10
- **Final completion:** 2017-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183297, "Study to Evaluate the Pharmacokinetics and Pharmacodynamics of JMI-001". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03183297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*